학술논문

Validation of the 16-Gene Recurrence Score in Patients with Locoregional, High-Risk Renal Cell Carcinoma from a Phase III Trial of Adjuvant Sunitinib
Document Type
Journal
Source
CLINICAL CANCER RESEARCH; SEP 15 2018, 24 18, p4407-p4415, 9p.
Subject
Language
English
ISSN
15573265